Jan 07, 2016 02:34 am UTC| Business
STEVENSON, Md., Jan. 06, 2016 (GLOBE NEWSWIRE) -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District...
Porter Ranch Residents’ Voices Are Finally Heard as Governor Brown Declares State of Emergency
Jan 07, 2016 02:17 am UTC| Business
PORTER RANCH, Calif., Jan. 06, 2016 (GLOBE NEWSWIRE) -- After a tremendous grassroots effort on the part of Porter Ranch residents, Governor Jerry Brown has finally declared a state of emergency following a massive gas...
Bank of Oak Ridge Announces Leadership Transition
Jan 07, 2016 02:05 am UTC| Business
OAK RIDGE, Jan. 06, 2016 (GLOBE NEWSWIRE) -- Oak Ridge Financial Services, Inc. (“Oak Ridge”; the “Company”), (OTCQB:BKOR), the parent company of Bank of Oak Ridge (“the Bank”), announced that Ron Black will be stepping...
Cempra Prices Public Offering of Common Stock
Jan 07, 2016 01:43 am UTC| Business
CHAPEL HILL, N.C., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial...
Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Aixtron SE (AIXG)
Jan 07, 2016 01:00 am UTC| Business
NEW YORK, Jan. 06, 2016 (GLOBE NEWSWIRE) -- Gainey McKenna Egleston announces that a class action lawsuit has been filed against Aixtron SE (“Aixtron” or the “Company”) (Nasdaq:AIXG) in the United District Court for the...
Jan 07, 2016 01:00 am UTC| Business
NEW YORK, Jan. 06, 2016 (GLOBE NEWSWIRE) -- Gainey McKenna Egleston announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL) in the United...
Otonomy Announces Pricing of Public Offering of Common Stock
Jan 07, 2016 00:39 am UTC| Business
SAN DIEGO, Jan. 06, 2016 (GLOBE NEWSWIRE) -- Otonomy, Inc.(NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear,...